Rosalyn completed a BSc in Experimental Psychology at the University of Bristol, and an MSc in Mental Health Studies at the Institute of Psychiatry. Since graduating, she has worked with individuals with autism, learning disabilities and 'challenging behaviour', across community and inpatient teams. She has also spent time working for LIFT (IAPT Services in Bristol) before working as an Assistant Psychologist with older adults in Memory Services and currently in an Autistic Spectrum Conditions Diagnostic team in North East Lincolnshire.
Rosalyn Nelson presents the findings of a small RCT of Pivotal Response Treatment groups for parents of children with autism, which has promising results in terms of encouraging children to communicate.
Rosalyn Nelson presents the latest Cochrane systematic review of Rivastigmine for Alzheimer’s disease, which brings together the results of 7 industry sponsored or funded trials, and concludes that Rivastigmine may be of benefit to people with Alzheimer’s disease.
Rosalyn Nelson reports on a recent systematic review about population screening for dementia, which highlights the negative attitudes of patients, carers and health care professionals towards screening. She asks: what are the risks of ignoring diagnosis?